Invention Grant
- Patent Title: Oncolytic rhabdovirus
- Patent Title (中): 溶瘤性弹状病毒
-
Application No.: US13514837Application Date: 2010-12-10
-
Publication No.: US09045729B2Publication Date: 2015-06-02
- Inventor: John C. Bell , David F. Stojdl
- Applicant: John C. Bell , David F. Stojdl
- Applicant Address: CA Ottawa CA Ottawa
- Assignee: Ottawa Hospital Research Institute,Children's Hospital of Eastern Ontario Research Institute Inc.
- Current Assignee: Ottawa Hospital Research Institute,Children's Hospital of Eastern Ontario Research Institute Inc.
- Current Assignee Address: CA Ottawa CA Ottawa
- Agency: Borden Ladner Gervais LLP
- Agent David Nauman
- International Application: PCT/IB2010/003396 WO 20101210
- International Announcement: WO2011/070440 WO 20110616
- Main IPC: A61K39/245
- IPC: A61K39/245 ; C12N7/00 ; A61K45/06
Abstract:
Embodiments of the invention include compositions and methods related to Maraba virus and their use as anti-cancer therapeutics. Such rhabdoviruses possess tumor cell killing properties in vitro and in vivo.
Public/Granted literature
- US20120275999A1 ONCOLYTIC RHABDOVIRUS Public/Granted day:2012-11-01
Information query
